Publications

Original Article

Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers

Tumor Microenvironment

2020

Authors:

Disis ML, Corulli LR, Gad EA, Koehnlein MR, Cecil DL, Senter PD, Gardai SJ, Okeley NM.

Journal:

Molecular Cancer theraputics

Volume:

19(5)

Page:

1102-1109

Pubmed:

Original Article

Gene expression markers of Tumor Infiltrating Leukocytes

Tumor Microenvironment

2017

Authors:

Danaher P, Warren S, Dennis L, D'Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J, Fling SP.

Journal:

Journal of Immunotherapy Cancer

Volume:

5

Page:

18

Pubmed:

Original Article

Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial

Tumor Microenvironment

2017

Authors:

Salazar, LG, Lu, H, Reichow, JL, Childs, JS, Coveler, AL, Higgins, DM, Waisman, J, Allison, KH, Dang, Y, and Disis, ML

Journal:

JAMA Oncology

Volume:

3(7)

Page:

969-973

Pubmed:

Original Article

Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity

Tumor Microenvironment

2016

Authors:

Dietsch GN, Lu H, Yang Y, Morishima C, Chow LQ, Disis ML, Hershberg RM.

Journal:

PLoS One

Volume:

11(2)

Page:

e0148764

Pubmed:

Original Article

Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation

Tumor Microenvironment

2014

Authors:

Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H

Journal:

Innate Immunity / Sage Journals

Volume:

20(8)

Page:

857-66

Pubmed:

Original Article

Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK

Tumor Microenvironment

2013

Authors:

Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML, Lu H.

Journal:

Cancer Immunology Immunotherapy

Volume:

62(8)

Page:

1335-45

Pubmed:

Original Article

Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant

Tumor Microenvironment

2013

Authors:

Engel AL, Sun GC, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H

Journal:

immunobiology

Volume:

218(12)

Page:

1468-76

Pubmed:

Original Article

Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation

Tumor Microenvironment

2013

Authors:

Yang, Y., Inatsuka, C., Gad, E., Disis, M.L., Standish, L.J., Pugh, N., Pasco, D.S. and Lu, H

Journal:

Innate Immunity / Sage Journals

Volume:

20(8)

Page:

857-66

Pubmed:

Original Article

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC

Tumor Microenvironment

2012

Authors:

Lu H., Dietsch G. N., Matthews M. A., Yang Y., Ghanekar S., Inokuma M., Suni M., Maino V. C., Henderson K. E., Howbert J. J., Disis M. L., Hershberg R. M.

Journal:

Clinical Cancer Research

Volume:

18(2)

Page:

499-509

Pubmed:

Original Article

Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells

Tumor Microenvironment

2012

Authors:

Dang Y, Wagner WM, Gad E, Rastetter L, Berger CM, Holt GE, Disis ML.

Journal:

Clinical Cancer Research

Volume:

18(11)

Page:

3122-31

Pubmed: